Mahamaya Lifesciences Limited IPO
BSE SME₹ 273600 /2400 Shares
*Min Investment
11 Nov, 2025
Open Date13 Nov, 2025
Close Date14 Nov, 2025
Allotment Date18 Nov, 2025
Listing DateMahamaya Lifesciences IPO Issue Details
- Issue Price ₹108-114 per equity share
- Face Value ₹10 Per Equity Share
- Total Issue Size 61,78,800 shares(aggregating up to ₹70.44 crore)
- Fresh Share 56,38,800 shares(aggregating up to ₹64.28 crore)
- Offer For Sale 5,40,000 shares(aggregating up to ₹6.16 crore)
- Listing at BSE SME
- Lead Manager Oneview Corporate Advisors Pvt.Ltd
- Registrar Kfin Technologies Ltd
Market Lot Size
Investors can bid for a minimum of 2400 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual (min) | 2 | 2400 | ₹2,73,600 |
| Individual(max) | 2 | 2400 | ₹2,73,600 |
| SHNI(min) | 3 | 3600 | ₹4,10,400 |
| SHNI(max) | 7 | 8400 | ₹9,57,600 |
| BHNI(min) | 8 | 9600 | ₹10,94,400 |
Mahamaya Lifesciences IPO Reservation
Mahamaya Lifesciences IPO offers total 61,78,800 shares. Out of which 11,76,000 (19.03%) allocated to QIB, 8,82,000 (14.27%) allocated to NII,20,59,200 (33.33%) allocated to RII, NA (NA%) allocated to employees and 17,52,000 (28.36%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 17,52,000 (28.36%) | |
| Market Maker Shares Offered | 3,09,600 (5.01%) | |
| QIB Shares Offered | 11,76,000 (19.03%) | |
| NII (HNI) Shares Offered | 8,82,000 (14.27%) | |
| bNII < ₹10L | 5,88,000 (9.52%) | |
| sNII < ₹10L | 2,94,000 (4.76%) | |
| Individual Shares Offered | 20,59,200 (33.33%) | |
| Total Shares Offered | 61,78,800 (100%) |
Mahamaya Lifesciences IPO Details
Mahamaya Lifesciences Limited IPO is an SME IPO, priced at ₹108-114 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the BSE SME platform. The IPO comprises a total issue of 61,78,800 equity shares, aggregating up to ₹70.44 crores..
The IPO bidding window is open from Nov 11, 2025 to Nov 13, 2025. The allotment is expected to be finalized on Nov 14, 2025, and the tentative listing date is Nov 18, 2025.
The minimum lot size for Individual investors is 2400 shares, with a minimum investment of ₹2,73,600.
Oneview Corporate Advisors Pvt.Ltd is acting as the lead manager to the issue. The registrar of the IPO is Kfin Technologies Ltd, and
Mahamaya Lifesciences Valuations
Mahamaya Lifesciences Company Financials
| 30-Jun-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|---|
| Assets | 218.87 | 188.35 | 112.07 | 77.88 |
| Revenue | 84.04 | 267.17 | 162.83 | 137.40 |
| Profit After Tax | 4.10 | 12.94 | 5.22 | 3.75 |
| Net Worth | 53.50 | 49.42 | 24.66 | 19.44 |
| Reserves & Surplus | 35.73 | 31.66 | 23.41 | 18.19 |
| Total Borrowing | 57.72 | 58.11 | 54.63 | 24.37 |
About Mahamaya Lifesciences Company
Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration, and export of the finest crop protection products and bio-products for crop & soil health management and to help the farming community for more productivity.
The company has developed considerable expertise in the manufacture of pesticide formulations and bulk products for Indian agrochemical companies and MNCs.It imports carefully researched molecules, gets them registered with the Central Insecticides Board, and sells them as technical and value-added formulations to domestic manufacturers and MNCs.
The company has invested in global product registrations, with active markets including the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations.
Mahamaya Lifesciences - Promoter(s)
Mr. Krishnamurthy Ganesan
Mrs. Lalitha Krishnamurthy
Mr. Prashant Krishnamurthy
Pre Issue Share Holding : 77.27%
Post Issue Share Holding : 56.35%
Mahamaya Lifesciences IPO - Issue Objectives
Purchase of Equipment for existing Formulation plant
Funding capital expenditure towards setting up of a new technical manufacturing plant
Construction of Warehouse Building and Purchase of Machinery
Funding working capital requirement of our Company
General corporate purposes
Contact Details
Mahamaya Lifesciences
Unit No: DPT – 033, Ground Floor, Plot No: 79 – 80, DLF Prime Tower, Block, Okhla, Phase – 1, Delhi, New Delhi, 110020
+91-1146561474
Registrar Contact Details
Kfin Technologies Limited
04067162222, 04079611000
Mahamaya Lifesciences IPO - FAQs
Ans. Mahamaya Lifesciences Limited IPO is a SME IPO. The issue is priced at ₹108-114 per equity share. The minimum order quantity is 1200 Shares. The IPO opens on Nov 11, 2025, and closes on Nov 13, 2025. Kfin Technologies Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Ans. The Mahamaya Lifesciences Limited IPO opens on Nov 11, 2025 and closes on Nov 13, 2025.
Ans. You can track the real-time subscription numbers using the links below:
Ans. The size of Mahamaya Lifesciences Limited IPO is 61,78,800 shares(aggregating up to ₹70.44 Cr).
Ans. The Mahamaya Lifesciences Limited IPO price band is set between ₹108-114 per equity share.
Ans. To apply for Mahamaya Lifesciences Limited IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Mahamaya Lifesciences Limited IPO in the List of IPOs
- - Press Apply Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Mahamaya Lifesciences Limited IPO is Nov 14, 2025.
Ans. The Mahamaya Lifesciences Limited IPO will be listed on Nov 18, 2025.
Ans. Follow the steps to check the Mahamaya Lifesciences Limited IPO allotment status online.
